Hims & Hers Health Q3 2023 Gaap EPS $(0.04) Misses $(0.03) Estimate, Sales $226.70M Beat $220.05M Estimate
Portfolio Pulse from saritha@benzinga.com
Hims & Hers Health (NYSE:HIMS) reported Q3 2023 GAAP EPS of $(0.04), missing the estimate of $(0.03) by 33.33%. However, the company's sales of $226.70M beat the estimate of $220.05M by 3.02%. This represents a 55.56% increase in losses and a 56.52% increase in sales compared to the same period last year.
November 06, 2023 | 9:23 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Hims & Hers Health's Q3 2023 earnings missed estimates, but sales exceeded expectations. This mixed result could lead to uncertain market reactions.
Hims & Hers Health's earnings miss could negatively impact the stock price, but the sales beat could offset this. The net effect on the stock price is uncertain, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100